Human immunodeficiency virus type 1

Virus Human immunodeficiency virus type 1
Disease
Aliases
Host Human
Virus Protein
Description
PMID

Editing sites

Virus Aliases Edited gene EG Aliases Editing Type Editing enzymes Nucleotide change Amino Acid Change Molecular Consequence Phenotype Disease
Human immunodeficiency virus type 1 G-to-A APOBEC3C Contribute to viral diversity
Human immunodeficiency virus type 1 G-to-A APOBEC3G Antiviral
Human immunodeficiency virus type 1 G-to-A APOBEC3G Antiviral
Human immunodeficiency virus type 1 G-to-A APOBEC3 Antiviral
Human immunodeficiency virus type 1 G-to-A APOBEC3G Antiviral
Human immunodeficiency virus type 1 A-to-I APOBEC3 These mutation may preexist in proviral reser
Human immunodeficiency virus type 1 C-to-U APOBEC3G Antiviral
Human immunodeficiency virus type 1 G-to-A APOBEC3G No evidence supporting an impact of APOBEC3 a
Human immunodeficiency virus type 1 NA APOBEC3A Antiviral
Human immunodeficiency virus type 1 NA ADAR2 ADAR2 does not increase the infectious potent
Human immunodeficiency virus type 1 G-to-A APOBEC3H Slowing viral diversification; Escape from im
Human immunodeficiency virus type 1 NA APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 NA APOBEC3G Antiviral
Human immunodeficiency virus type 1 NA APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G Antiviral
Human immunodeficiency virus type 1 ADAR1 The editing enzyme is incorporated into viral
Human immunodeficiency virus type 1 APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3A Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3F Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3 Inhibit viral replication
Human immunodeficiency virus type 1 AID Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3A Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3A Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 ADAR1 Promote viral replication
Human immunodeficiency virus type 1 APOBEC3H Antiviral
Human immunodeficiency virus type 1 APOBEC3G Antiviral
Human immunodeficiency virus type 1 APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G Antiviral
Human immunodeficiency virus type 1 APOBEC3G Prevents the formation of functional provirus
Human immunodeficiency virus type 1 APOBEC3G Resulting in G to A hypermutation in the plus
Human immunodeficiency virus type 1 APOBEC3G Association with the viral nucleoprotein comp
Human immunodeficiency virus type 1 APOBEC3G Antiviral
Human immunodeficiency virus type 1 APOBEC3G Antiviral
Human immunodeficiency virus type 1 APOBEC3G Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G Deaminase inhibition
Human immunodeficiency virus type 1 APOBEC3G Not necessary for antiviral activity
Human immunodeficiency virus type 1 APOBEC3F Antiviral
Human immunodeficiency virus type 1 APOBEC3F Antiviral
Human immunodeficiency virus type 1 APOBEC3G Antiviral
Human immunodeficiency virus type 1 APOBEC3F Inhibit viral replication
Human immunodeficiency virus type 1 APOBEC3G not necessary for antiviral activity
Human immunodeficiency virus type 1 ADAR1 Stimulate viral infection